To conclude, our findings suggest that WNT-1 levels in the membrane may be used to rule out high-risk neoplasms, whereas cytoplasmic WNT-1 and nuclear mTOR may be used for confirmation of high-risk endometrial cancer. The gene discussed is WNT1; the disease is neoplasm.